There are certain hormones that can attach to breast cancer cells and affect their ability to multiply. The purpose of hormone therapy, also called endocrine therapy, is to add, block, or remove hormones.
Breast reconstruction can be done right after a mastectomy while you are still under anesthesia, or at a later time. Sometimes women wait because they are not emotionally or medically able to undergo additional surgery, or because they need radiation therapy following their breast cancer and mastectomy. Reconstruction is major surgery that may require more than one procedure. Women should be fully informed about what is involved.
Women have several options in breast reconstruction surgery, including...
There are two types of hormone therapy for breast cancer.
Drugs that inhibit estrogen and progesterone from promoting breastcancer cell growth.
Drugs or surgery to turn off the production of hormones from the ovaries.
Do not confuse the term hormone therapy that is used for treating women with breastcancer with hormone replacement therapy that is typically used by postmenopausal women. Hormone therapy for cancer treatment stops hormones from getting to breast cancer cells. Hormone therapy for postmenopausal women without cancer adds more hormones to your body to counter the effects of menopause.
Who Gets Hormone Therapy for Breast Cancer?
As part of the diagnosis process, tests are done to determine if the breast cancer cells have estrogen or progesterone receptors. If so, that means that growth of the cancer can be stimulated with these hormones. If a cancer is found to have these receptors, hormone therapy is recommended as part of the treatment plan.
What Hormone Therapy Drugs Are Used for Breast Cancer?
There are several common hormone therapy drugs used for breast cancer:
Tamoxifen is a pill that has been used for over 30 years to treat breast cancer. It was first used in metastatic breast cancer (cancer that spread) because it slowed or stopped the growth of cancer cells in the body. Tamoxifen also decreases the chance that some early-stage breast cancers will recur in premenopausal or postmenopausal women and it can reduce the risk of cancer developing in the unaffected breast.